Age-related androgen deficiency and type 2 diabetes

Gina J. Ryan, Lynetta Johnson Jobe

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

There is a higher prevalence of low testosterone levels in males with type 2 diabetes compared to those without. Additionally, there is evidence that low testosterone levels may predict the development of type 2 diabetes. Symptoms of hypogonadism include decreased libido, decreased bone mineral density (BMD), and decreased lean muscle mass. The majority of the published cases in men with diabetes were attributed to age-related idiopathic hypogonadotropic hypogonadism. This paper reviews the link between type 2 diabetes and age-related hypogonadism and the treatment options for hypogonadism. Pharmacists who provide care for males with diabetes should be aware of the increased incidence of hypogonadism, know how to screen for it, and be able to recommend appropriate therapy.

Original languageEnglish (US)
Pages (from-to)316-322
Number of pages7
JournalJournal of Pharmacy Practice
Volume24
Issue number3
DOIs
StatePublished - Jun 1 2011

Fingerprint

Hypogonadism
Type 2 Diabetes Mellitus
Androgens
Testosterone
Libido
Pharmacists
Bone Density
Muscles
Incidence
Therapeutics

Keywords

  • andropause
  • diabetes
  • hypogonadism
  • men's health
  • testosterone

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Age-related androgen deficiency and type 2 diabetes. / Ryan, Gina J.; Jobe, Lynetta Johnson.

In: Journal of Pharmacy Practice, Vol. 24, No. 3, 01.06.2011, p. 316-322.

Research output: Contribution to journalArticle

Ryan, Gina J. ; Jobe, Lynetta Johnson. / Age-related androgen deficiency and type 2 diabetes. In: Journal of Pharmacy Practice. 2011 ; Vol. 24, No. 3. pp. 316-322.
@article{bf9fd00be90f415e8d994a970fdb0085,
title = "Age-related androgen deficiency and type 2 diabetes",
abstract = "There is a higher prevalence of low testosterone levels in males with type 2 diabetes compared to those without. Additionally, there is evidence that low testosterone levels may predict the development of type 2 diabetes. Symptoms of hypogonadism include decreased libido, decreased bone mineral density (BMD), and decreased lean muscle mass. The majority of the published cases in men with diabetes were attributed to age-related idiopathic hypogonadotropic hypogonadism. This paper reviews the link between type 2 diabetes and age-related hypogonadism and the treatment options for hypogonadism. Pharmacists who provide care for males with diabetes should be aware of the increased incidence of hypogonadism, know how to screen for it, and be able to recommend appropriate therapy.",
keywords = "andropause, diabetes, hypogonadism, men's health, testosterone",
author = "Ryan, {Gina J.} and Jobe, {Lynetta Johnson}",
year = "2011",
month = "6",
day = "1",
doi = "10.1177/0897190010397719",
language = "English (US)",
volume = "24",
pages = "316--322",
journal = "Journal of Pharmacy Practice",
issn = "0897-1900",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Age-related androgen deficiency and type 2 diabetes

AU - Ryan, Gina J.

AU - Jobe, Lynetta Johnson

PY - 2011/6/1

Y1 - 2011/6/1

N2 - There is a higher prevalence of low testosterone levels in males with type 2 diabetes compared to those without. Additionally, there is evidence that low testosterone levels may predict the development of type 2 diabetes. Symptoms of hypogonadism include decreased libido, decreased bone mineral density (BMD), and decreased lean muscle mass. The majority of the published cases in men with diabetes were attributed to age-related idiopathic hypogonadotropic hypogonadism. This paper reviews the link between type 2 diabetes and age-related hypogonadism and the treatment options for hypogonadism. Pharmacists who provide care for males with diabetes should be aware of the increased incidence of hypogonadism, know how to screen for it, and be able to recommend appropriate therapy.

AB - There is a higher prevalence of low testosterone levels in males with type 2 diabetes compared to those without. Additionally, there is evidence that low testosterone levels may predict the development of type 2 diabetes. Symptoms of hypogonadism include decreased libido, decreased bone mineral density (BMD), and decreased lean muscle mass. The majority of the published cases in men with diabetes were attributed to age-related idiopathic hypogonadotropic hypogonadism. This paper reviews the link between type 2 diabetes and age-related hypogonadism and the treatment options for hypogonadism. Pharmacists who provide care for males with diabetes should be aware of the increased incidence of hypogonadism, know how to screen for it, and be able to recommend appropriate therapy.

KW - andropause

KW - diabetes

KW - hypogonadism

KW - men's health

KW - testosterone

UR - http://www.scopus.com/inward/record.url?scp=79958129611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958129611&partnerID=8YFLogxK

U2 - 10.1177/0897190010397719

DO - 10.1177/0897190010397719

M3 - Article

C2 - 21676855

AN - SCOPUS:79958129611

VL - 24

SP - 316

EP - 322

JO - Journal of Pharmacy Practice

JF - Journal of Pharmacy Practice

SN - 0897-1900

IS - 3

ER -